The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.
The Scientist
Most Recent
Over the past 15 years, new laws and regulations in the United States and the European Union have expanded to require the inclusion of pediatric patients in clinical drug trials. Before these laws were enacted, the US Food and Drug Administration (F
When children need medications, getting the dosing and method of administration right is like trying to hit a moving target with an untried weapon.
Pharmacovigilance must keep pace with global distribution of drugs in resource-limited settings.
As seven of the world’s top selling drugs expire over the next year, prescription prices are set to drop while generics fill in.
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
